TAGCyx Biotechnologies

About

TagCyx is a research based company based in Tokyo (Japan), founded in March 2007 as a spin out company of RIKEN.

Tokyo,Tokyo,Japan
1 - 10

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: ¥210M
Industries: Biotechnology,Environmental Consulting
Founded date: Mar 1, 2007
Number Of Employee: 1 - 10
Operating Status: Active
Legal Name: TAGCyx Biotechnologies, Inc.
Also Known As: TagCyx

TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

¥1.41B

TAGCyx Biotechnologies has raised a total of ¥1.41B in funding over 2 rounds. Their latest funding was raised on Jul 7, 2021 from a Series Unknown round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 7, 2021	Series Unknown	¥210M	3	—	—	Detail
Apr 27, 2020	Series Unknown	¥200M	1	—	—	Detail
Apr 24, 2018	Series B	¥500.25M	4	—	—	Detail
Aug 31, 2016	Series Unknown	¥500M	3	UTEC - The University of Tokyo Edge Capital Partners	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

7

TAGCyx Biotechnologies is funded by 7 investors. Healthcare Innovation and SBI Group are the most recent investors.

Investor Name	Lead Investor	Funding Round
Healthcare Innovation	—	Series Unknown
SBI Group	—	Series Unknown
UTokyo Innovation Platform	—	Series Unknown
Mizuho Capital	—	Series B
SMBC Venture Capital	—	Series B
UTEC - The University of Tokyo Edge Capital Partners	—	Series B
Nissay Capital	—	Series Unknown